BERKELEY HEIGHTS, N.J., Jan. 6, 2011 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today reviewed 2010 achievements and outlined the Company's key clinical development objectives for 2011, which will be highlighted at the Company's presentation during the 4th Annual OneMedForum Business Development and Investment Conference at 11:30 am Pacific Time on January 11, 2011, at the Sir Francis Drake Hotel in San Francisco.